Indometacin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Enzyme inhibitors |
Catalog number | BBF-04026 |
CAS | 53-86-1 |
Molecular Weight | 357.79 |
Molecular Formula | C19H16ClNO4 |
Purity | 98% |
Online Inquiry
Description
A nonselective COX1 and COX2 inhibitor with IC50 of 0.1 μg/mL and 5 μg/mL, respectively.
Specification
Synonyms | 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid |
Storage | Store at -20°C |
IUPAC Name | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid |
Canonical SMILES | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O |
InChI | InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) |
InChI Key | CGIGDMFJXJATDK-UHFFFAOYSA-N |
Properties
Appearance | Off-white Solid |
Application | API |
Boiling Point | 499.4°C at 760 mmHg |
Melting Point | 159-161°C |
Density | 1.32 g/cm3 |
LogP | 4.27 |
Toxicity
Carcinogenicity | No indication of carcinogenicity to humans (not listed by IARC). |
Mechanism Of Toxicity | Antiinflammatory effects of Indomethacin are believed to be due to inhibition of cylooxygenase in platelets which leads to the blockage of prostaglandin synthesis. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Indomethacin is a prostaglandin G/H synthase (also known as cyclooxygenase or COX) inhibitor that acts on both prostaglandin G/H synthase 1 and 2 (COX-1 and -2). Prostaglandin G/H synthase catalyzes the conversion of arachidonic acid to a number of prostaglandins involved in fever, pain, swelling, inflammation, and platelet aggregation. Indomethacin antagonizes COX by binding to the upper portion of the active site, preventing its substrate, arachidonic acid, from entering the active site. Indomethacin, unlike other NSAIDs, also inhibits phospholipase A2, the enzyme responsible for releasing arachidonic acid from phospholipids. Indomethacin is more selective for COX-1 than COX-2, which accounts for its increased adverse gastric effects relative to other NSAIDs. COX-1 is required for maintaining the protective gastric mucosal layer. The analgesic, antipyretic and anti-inflammatory effects of indomethacin occur as a result of decreased prostaglandin synthesis. Its antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. |
Toxicity | LD50: 50 mg/kg (oral, mice) (based on 14 day mortality response); LD50: 12 mg/kg (oral, rat) (based on 14 day mortality response). |
Reference Reading
Spectrum
GC-MS Spectrum - EI-B (Non-derivatized)
Experimental Conditions
Ionization Mode: positive
Chromatography Type: GC
Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive
Experimental Conditions
Ionization Energy: 70 eV
Chromatography Type: Gas Chromatography Column (GC)
Instrument Type: Single quadrupole, spectrum predicted by CFM-ID(EI)
Mass Resolution: 0.0001 Da
Molecular Formula: C19H16ClNO4
Molecular Weight (Monoisotopic Mass): 357.0768 Da
Molecular Weight (Avergae Mass): 357.788 Da
LC-MS/MS Spectrum - LC-ESI-qTof , Positive
Experimental Conditions
Ionization Mode: Positive
Predicted LC-MS/MS Spectrum - 10V, Positive
Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
Molecular Formula: C19H16ClNO4
Molecular Weight (Monoisotopic Mass): 357.0768 Da
Molecular Weight (Avergae Mass): 357.788 Da
Mass Spectrum (Electron Ionization)
1H NMR Spectrum
Experimental Conditions
Instrument Type: JEOL
Nucleus: 1H
Frequency: 400 MHz
Chemical Shift Reference: TMS
Recommended Products
BBF-00764 | Cerebroside C | Inquiry |
BBF-03754 | Castanospermine | Inquiry |
BBF-05862 | Epirubicin | Inquiry |
BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
BBF-00677 | 3-Amino-3-deoxy-D-glucose | Inquiry |
BBF-03755 | Actinomycin D | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2